Stock comparison
Medline Inc. is 46.4x more valuable than TANDEM DIABETES CARE INC by market capitalization ($49.12 B vs $1.06 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MDLN is larger
Medline Inc. is 46.4x more valuable than TANDEM DIABETES CARE INC by market capitalization ($49.12 B vs $1.06 B).
Market value leader
MDLN
Medline Inc. is 46.4x more valuable than TANDEM DIABETES CARE INC by market capitalization ($49.12 B vs $1.06 B).
Revenue leader
MDLN
TNDM: $1.01B vs MDLN: $28.43B.
Profit leader
MDLN
TNDM: -$204.70M vs MDLN: $1.16T.
Margin leader
MDLN
TNDM: -20.2% vs MDLN: 4069.4% net margin.
| Metric | TNDM | MDLN |
|---|---|---|
| Market cap | $1.06 B | $49.12 B |
| US-listed rank | #2600 | #328 |
| Revenue (latest FY) | $1.01B | $28.43B |
| Net income (latest FY) | -$204.70M | $1.16T |
| Net margin | -20.2% | 4069.4% |
| P/E (trailing FY) | - | 0.0x |
| SEC filings | 1,234 | 103 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Medline Inc. is 46.4x more valuable than TANDEM DIABETES CARE INC by market capitalization ($49.12 B vs $1.06 B).
In their latest fiscal years, TANDEM DIABETES CARE INC reported $1.01B in revenue while Medline Inc. reported $28.43B.
Full pages: TANDEM DIABETES CARE INC and Medline Inc., or browse the full rankings.